4.7 Article

Impact of Rome IV Irritable Bowel Syndrome on Work and Activities of Daily Living

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Comparing Costs and Outcomes of Treatments for Irritable Bowel Syndrome With Diarrhea: Cost-Benefit Analysis

Eric D. Shah et al.

Summary: This study assessed the cost-benefit of treatments for IBS with diarrhea from insurer and patient perspectives, finding that prescription drugs and neuro-modulators were preferred by patients due to reduced lost wages and out-of-pocket costs. Costs were critical determinants of treatment value, with divergent cost drivers explaining misalignment between patient and insurer preferences.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Willingness to accept risk with medication in return for cure of symptoms among patients with Rome IV irritable bowel syndrome

Vivek C. Goodoory et al.

Summary: The study found that patients with IBS are willing to accept higher risks for the cure of their symptoms. Men, those with continuous abdominal pain, more severe symptoms, depression, higher gastrointestinal symptom-specific anxiety, and lower IBS-related quality of life are more willing to accept risks for treatment.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)

Article Gastroenterology & Hepatology

Maintaining work life under threat of symptoms: a grounded theory study of work life experiences in persons with Irritable Bowel Syndrome

Asa Frandemark et al.

Summary: This study provides a deeper understanding of the work situation for individuals with Irritable Bowel Syndrome (IBS). The results suggest that although balancing work life under the threat of symptoms can be challenging, there are strategies that individuals with IBS and employers can initiate and use to reduce the impact on work.

BMC GASTROENTEROLOGY (2022)

Article Gastroenterology & Hepatology

Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom

Vivek C. Goodoory et al.

Summary: This study provides contemporary estimates of direct healthcare costs of IBS in the UK, finding that individuals with opiate use, more severe symptoms, shorter duration of IBS, lower quality of life, and higher levels of depression require higher healthcare costs.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)

Article Gastroenterology & Hepatology

The Role of Resilience in Irritable Bowel Syndrome, Other Chronic Gastrointestinal Conditions, and the General Population

Colleen H. Parker et al.

Summary: The study found that resilience is lower in patients with Irritable Bowel Syndrome (IBS) compared to the general population, leading to more severe symptoms. The impact of global mental health on resilience is more significant in IBS compared to the general population, and early adverse life events also decrease the ability to bounce back from adversity. While resilience in IBS is lower than the general US population, it is comparable to other chronic gastrointestinal conditions.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care

Christopher J. Black et al.

Summary: In a study conducted in the UK, researchers found that the Rome IV criteria performed better than the Rome III criteria in diagnosing IBS, with a sensitivity of 82.4% and specificity of 82.9%. The Rome IV criteria showed better performance in patients with constipation or mixed bowel habits.
Article Gastroenterology & Hepatology

Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel Syndrome

Vivek C. Goodoory et al.

Summary: The prognosis of individuals with Rome IV-defined IBS worsens according to incremental increases in psychological comorbidity. This finding has significant implications for clinical practice and research.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

British Society of Gastroenterology guidelines on the management of irritable bowel syndrome

Dipesh H. Vasant et al.

Summary: This guideline aims to review and summarize current evidence on irritable bowel syndrome (IBS) to inform clinical practice and provide guidance, with specific treatment recommendations based on evidence from a comprehensive search of medical literature. The guideline highlights the efficacy of dietary, pharmacological, and psychological therapies in treating IBS, and provides specific recommendations according to the Grading of Recommendations Assessment, Development, and Evaluation system.
Review Gastroenterology & Hepatology

A Review of the Evidence and Recommendations on Communication Skills and the Patient-Provider Relationship: A Rome Foundation Working Team Report

Douglas A. Drossman et al.

Summary: The changes in healthcare have negatively impacted the communication between patients and providers, but evidence shows that communication skills training can improve patient satisfaction and outcomes. More research is needed to confirm these findings and to further explore the role of communication skills in healthcare.

GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Longitudinal follow-up of a novel classification system for irritable bowel syndrome: natural history and prognostic value

Christopher J. Black et al.

Summary: The study conducted a longitudinal follow-up on IBS patients, finding that cluster membership stratified according to psychological burden was more stable and predictive of disease course. Those with high psychological burden at baseline had more severe symptoms, received more treatments, and were more likely to consult a doctor.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)

Review Gastroenterology & Hepatology

Improving Patient-Provider Relationships to Improve Health Care

Douglas A. Drossman et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Review Gastroenterology & Hepatology

Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis

Priya Oka et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Review Medicine, General & Internal

Functional gastrointestinal disorders: advances in understanding and management

Christopher J. Black et al.

LANCET (2020)

Article Gastroenterology & Hepatology

Effects of Irritable Bowel Syndrome on Daily Activities Vary Among Subtypes Based on Results From the IBS in America Survey

Sarah Ballou et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

Article Gastroenterology & Hepatology

Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial

Hazel A. Everitt et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)

Article Gastroenterology & Hepatology

Resilience is decreased in irritable bowel syndrome and associated with symptoms and cortisol response

S. H. Park et al.

NEUROGASTROENTEROLOGY AND MOTILITY (2018)

Article Gastroenterology & Hepatology

Work Productivity and Activity Impairment in Irritable Bowel Syndrome (IBS): A Multifaceted Problem

Asa Frandemark et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)

Article Gastroenterology & Hepatology

The impact of irritable bowel syndrome on daily functioning: Characterizing and understanding daily consequences of IBS

S. Ballou et al.

NEUROGASTROENTEROLOGY AND MOTILITY (2017)

Article Health Care Sciences & Services

Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea

Jessica L. Buono et al.

HEALTH AND QUALITY OF LIFE OUTCOMES (2017)

Article Gastroenterology & Hepatology

Bowel Disorders

Brian E. Lacy et al.

GASTROENTEROLOGY (2016)

Article Gastroenterology & Hepatology

Development and Validation of the Rome IV Diagnostic Questionnaire for Adults

Olafur S. Palsson et al.

GASTROENTEROLOGY (2016)

Review Gastroenterology & Hepatology

Pathophysiology of irritable bowel syndrome

Gerald J. Holtmann et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2016)

Editorial Material Medicine, General & Internal

Irritable bowel syndrome in adults in primary care: summary of updated NICE guidance

Cheryl Hookway et al.

BMJ-BRITISH MEDICAL JOURNAL (2015)

Editorial Material Medicine, General & Internal

Irritable bowel syndrome in adults in primary care: summary of updated NICE guidance

Cheryl Hookway et al.

BMJ-BRITISH MEDICAL JOURNAL (2015)

Review Rehabilitation

Quality of Working Life Issues of Employees with a Chronic Physical Disease: A Systematic Review

Merel de Jong et al.

JOURNAL OF OCCUPATIONAL REHABILITATION (2015)

Review Gastroenterology & Hepatology

Prevalence of Irritable Bowel Syndrome-type Symptoms in Patients With Celiac Disease: A Meta-analysis

Anita Sainsbury et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)

Article Gastroenterology & Hepatology

How patients with long-term experience of living with irritable bowel syndrome manage illness in daily life: a qualitative study

Eva Jakobsson Ung et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2013)

Article Primary Health Care

Long-term impact of irritable bowel syndrome: a qualitative study

Rebecca Farndale et al.

Primary Health Care Research and Development (2010)

Article Gastroenterology & Hepatology

A Focus Group Assessment of Patient Perspectives on Irritable Bowel Syndrome and Illness Severity

Douglas A. Drossman et al.

DIGESTIVE DISEASES AND SCIENCES (2009)

Article Gastroenterology & Hepatology

Irritable bowel syndrome: A 10-yr natural history of symptoms and factors that influence consultation behavior

Alexander C. Ford et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)

Article Gastroenterology & Hepatology

The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale

JS Labus et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)

Article Psychiatry

The Work and Social Adjustment Scale: a simple measure of impairment in functioning

JC Mundt et al.

BRITISH JOURNAL OF PSYCHIATRY (2002)